Cutler Group LP Enanta Pharmaceuticals Inc Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Jan 21, 2021	SELL	$41.16 - $47.47 $102,899 - $118,675	-2,500 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$46.37 - $57.58 $115,925 - $143,950	2,500 New	2,500 $20,000
Q2 2019 Aug 09, 2019	SELL	$81.3 - $97.35 $170,730 - $204,435	-2,100 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$69.08 - $105.66 $62,172 - $95,094	-900 Reduced 30.0%	2,100 $17,000
Q3 2018 Nov 07, 2018	BUY	$85.46 - $126.37 $222,195 - $328,562	2,600 Added 650.0%	3,000 $30,000
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $32,739 - $48,204	400 New	400 $0

107

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $102M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.